Stalled? 3 Reasons You Stopped Losing Weight on GLP-1s

You started semaglutide or tirzepatide, the weight came off beautifully for the first few months, and then somewhere around month three or four -- it stopped. The scale isn't moving. You're eating the same amount, following the same routine, but the results have flatlined. This is one of the most common and frustrating experiences in GLP-1 therapy, and it has specific and addressable causes.

I'm Dr. Farhan Abdullah at Magnolia Functional Wellness in Southlake. Here are the three most common reasons GLP-1 weight loss stalls -- and what to do about each.

1. Your Dose Hasn't Been Optimized

GLP-1 medications work on a dose-response curve. Semaglutide goes up to 2.4mg weekly (the Wegovy dose) and tirzepatide up to 15mg weekly. Most people start on a fraction of these doses and titrate up over several months to manage side effects. If weight loss has plateaued, the first question is: are you at your optimal dose, or have you stopped titrating because side effects at a lower dose were manageable and you assumed you were done?

Many patients on commercially prescribed GLP-1s get left at subtherapeutic doses because their physician titrates conservatively and then doesn't revisit the dose when progress stalls. If you're on 0.5mg or 1mg of semaglutide and weight loss has stopped, there's likely meaningful additional benefit available at higher doses. This is a dose conversation to have with your prescribing physician, not something to interpret as the medication failing.

2. Metabolic Adaptation Has Occurred

Your body is remarkably good at defending its weight. When significant weight is lost over several months, your resting metabolic rate decreases -- you're burning fewer calories at rest than you were before, both because you weigh less and because of adaptive thermogenesis, a metabolic downregulation that occurs in response to caloric restriction. This is a physiological response, not a failure of willpower or medication.

Combating metabolic adaptation requires preserving muscle mass, which is the primary metabolic tissue in your body. This is one of the most underemphasized aspects of GLP-1 therapy: the medication reduces appetite effectively but doesn't discriminate between fat and muscle loss. If you're losing weight on a GLP-1 without resistance training and adequate protein intake, a meaningful portion of that weight is lean mass -- and every pound of muscle lost further reduces your metabolic rate, accelerating the plateau.

Resistance training two to three times per week and protein intake of at least 1 gram per pound of target body weight are not optional recommendations at our weight loss program at Magnolia. They're foundational to sustainable outcomes.

3. An Underlying Metabolic or Hormonal Issue Is Counteracting the Medication

GLP-1s are powerful tools, but they can't fully overcome significant hormonal or metabolic obstacles running in the background. The most common culprits:

Hypothyroidism -- even subclinical thyroid dysfunction reduces metabolic rate and makes weight loss resistant. If your TSH hasn't been checked recently, check it. Low testosterone in men is another major driver of weight loss resistance -- testosterone directly affects insulin sensitivity, muscle mass maintenance, and fat distribution. A man on a GLP-1 with a testosterone of 250 is fighting against his own biology.

Insulin resistance -- paradoxically, significant insulin resistance can persist despite GLP-1 therapy and limit fat mobilization. Poor sleep quality elevates cortisol chronically, and elevated cortisol is powerfully anti-lipolytic. Certain medications, particularly antidepressants, antipsychotics, and corticosteroids, cause weight gain through mechanisms GLP-1s don't fully counter.

If weight loss has stalled on a GLP-1, the response isn't to assume the medication has stopped working. It's to do a systematic evaluation of what else might be running interference -- and that evaluation is exactly what functional medicine-integrated weight management is designed to do.